Febrile neutropenia is generally defined as a temperature >38.3 C (>101 F) and an absolute neutrophil count <500/mm3. Most cases are due to gram-positive pathogens such as Staphylococcus epidermidis (most common), Staphylococcus aureus, and streptococci, but gram-negative bacteria (eg, Pseudomonas) are isolated in approximately 25% of cases and are often associated with more severe illness.
Monotherapy with an anti-pseudomonal beta-lactam (eg, piperacillin-tazobactam, cefepime) or a carbapenem is considered first-line treatment in the inpatient setting. Studies have shown no improvement in mortality with the routine addition of a second agent (eg, vancomycin) targeting gram-positive pathogens. Indications for vancomycin include: